Showing results (11-20 of 174) with videos related to
Sort By:
Pageof 18
Cancer Treatment Reviews|June 10, 2021
Checkpoint inhibitors in metastatic papillary renal cell carcinomaM de Vries-Brilland, D F McDermott, C Suárez, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2010
Poor prognosis nonseminomatous germ-cell tumours (NSGCTs): should chemotherapy doses be reduced at first cycle to prevent acute respiratory distress syndrome in patients with multiple lung metastases?C Massard, A Plantade, M Gross-Goupil, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2010
Urinary N-telopeptide (uNTx) is an independent prognostic factor for overall survival in patients with bone metastases from castration-resistant prostate cancerS Rajpar, C Massard, A Laplanche, et al.Bulletin Du Cancer|June 11, 2010
[Bladder cancer and new drugs]C Massard, B Albouy, M Gross-Goupil, et al.Journal De Radiologie|September 28, 2011
[Rationale for the local treatment of metastases]A Ravaud, S Roca, A Quivy, et al.Presse Medicale (Paris, France : 1983)|October 28, 1995
[Immunotherapy in metastatic cancer of the kidney]B EscudierAnnals of Oncology : Official Journal of the European Society for Medical Oncology|August 25, 2012
Emerging immunotherapies for renal cell carcinomaB EscudierBulletin Du Cancer|April 27, 2010
[mTOR inhibitors: temsirolimus and everolimus in the treatment of renal cell carcinoma]A Ravaud, J-C Bernhard, M Gross-Goupil, et al.Annales Francaises D'Anesthesie Et De Reanimation|January 1, 1986
[Tracheal rupture during intubation for general anesthesia]C Jayr, B EscudierPageof 18